Saturday, April 26, 2008
SRL Ranbaxy has received expressions of interest (EoI) from several financial funds and talks are at a fairly advanced stage. However, the company has not finalised the financial details or the stake it would offload before its public issue.
Continue Reading: http://economictimes.indiatimes.com/News/News_By_Industry/PEs_banks_in_talks_to_buy_stake_in_SRL_Ranbaxy/articleshow/2976754.cms
All types of hospitals carry out clinical trials, large and small as also municipal and government hospitals. Large private hospitals and clinics too perform this work. The basic requirement is the presence of doctors who have an interest in this work.
Continue Reading: http://indiaonestop.com/clinicaltrials.htm
|Filling the vacuum in quality healthcare, diagnostic services|
|Ameera Patel / Mumbai Apr 19, 2008 09:39|
|Filling the vacuum in quality healthcare, diagnostic services metropolis identifies opportunities and trends in the coming financial year|
Healthcare, globally, is on a high-growth trajectory, with strong emphasis on the Asian and Middle East markets. Currently the global healthcare market is valued at over USD 6.68 trillion, 2005, and is growing at rate of 7.5%, which is much higher than the global GDP growth. It is estimated that Asia currently constitutes around 34% of the healthcare market. This figure is expected to increase to about 45% by 2008 and projects opportunities for the Indian health care in the global pharmaceutical and diagnostic markets. The Indian healthcare industry alone is ready to rocket from a USD 20.6 billion industry in 2001 to an expected USD 60 billion by 2010, led by strong demand. The Indian healthcare industry employs over four million people, which makes it one of the largest service sectors in the economy. The extended reach of healthcare due to the advancement in technology and creation of an E-world has led to Remote diagnostics, surgeries, monitoring of chronic conditions; Specialist conditions; Email consultations for primary care; E-prescriptions; Electronic health records and Telemedicine, which has further led to borderless healthcare services.
Continue Reaading: http://www.indiainfoline.com/news/innernews.asp?storyId=65195&lmn=1
Monday, April 21, 2008
Sneha Diagnostics has unveiled plans to open 10 diagnostic centres in all major district centres across the state of Andhra Pradesh, India. After completing the first phase, it desires to go for a public issue and / or venture capital with a focus to reach remote corners of India. Sneha Diagnostics currently owns and operates three diagnostics centres in the towns of Ongole and Chirala of Prakasam District and Kavali of Nellore District in Andhra Pradesh, India.
The new facilities will be located in all major district centres of Andhra Pradesh, India. The organisation has plans to set up more centres in second-tier cities and remote places all over India.
Saturday, April 19, 2008
If inefficiency is the path to opportunity, the future for India's health care sector may be bright. Just how close that future is varies by market segment. In the case of life sciences, its arrival could coincide with industry participants' greater willingness to accept risk, while health insurance could seize its day amid rising treatment costs. As for health care delivery's chance to shine, that could be more in the distant future, stymied by a lack of infrastructure investment and trained professionals.
Two recent conference panels, one at Wharton and the other at Harvard University, explored the state of India's health care system. Among the conclusions: Government and industry need to increase health care investment and employment and make high-quality care more affordable and available to all.
A source told ET, "SRL Ranbaxy is in advanced talks with a few PE firms as part of the pre-IPO sale. The company is looking at forging a strategic alliance with Fortis Healthworld, wherein the latter would also divest some of its stake.
There is a possibility that a PE fund may get to pick up stakes in both the companies. Officials of both Fortis Healthworld and SRL Ranbaxy—separate companies of the Fortis Group — were not available for comment.
Glucocard 01 offers a high level of accuracy and precision in the self-monitoring of blood glucose due to the use of sophisticated and unique biosensor technology. In addition, Glucocard 01 ensures a virtually pain-free testing experience for the diabetic patient.
Biosensor technology is accepted as being superior, since its accuracy and precision are far greater than obtained with photometer technology, which is commonly used in other glucometers.
Continue Reading: http://www.powerhomebiz.com/News/042008/arkray-piramal.htm
Opto Circuits (India) Limited, India's leading manufacturer of medical diagnostics and interventional products, today announced that it has successfully completed acquisition of Criticare Systems, Inc, a leading USbased healthcare ...
Sunday, April 13, 2008
With the recent notification of the revised schedule Y of the Drugs & Cosmetics Act allowing simultaneous Phase II & III trials in India and the rest of the world, clinical research outsourcing to India is set to boom. With current revenues of $100 million, the clinical research industry is set to grow 80% in 2005, predicts market-research firm SCOPE. While CenterWatch estimates the industry to reach a size of $300 million in the next five years, others like The Boston Consulting Group are more bullish projecting a $500 million turnover by 2010. It is estimated that 20% of all global clinical trials will be from India by then.
Saturday, April 12, 2008
Seedfund, India's leading early-stage venture capital firm, and Aavishkaar India MVCF, have entered into a joint equity investment for Vaatsalya, a healthcare services startup which already has its hospitals in North Karntaka. The healthcare company is spearheading the establishment of India's first hospital network in semi-urban areas within the country and will offer primary and secondary care services
"This investment will enable Vaatsalya to create additional hospitals to provide much needed efficient and affordable healthcare services for large semi urban and rural families across India," said Dr. Ashwin Naik, Founder/CEO, Vaatsalya Healthcare Solutions Pvt. Ltd.
Although India's metros and semi-urban areas are witnessing the mushrooming of corporate healthcare chains, basic healthcare services available in semi-urban and rural India have a long way to go. A commitment to bridge this gap in healthcare equity in semi-urban and rural areas formed the basis for birth of the very first Vaatsalya Hospital in the year 2005.Read complete story: http://www.indiaprwire.com/pressrelease/health-care/200804118712.htm?aid=2583
Thursday, April 10, 2008
How rare is your rarest blood group? If you are a special blood type found in only one in 100, please enlist in Voluntary Blood Donors Hotline
Blood is a lifeline. Timely blood donation saves many. Everybody has it and everybody needs it. But, nobody donates it. Donate blood. Save lives. Especially rare blood group donors must come forward and donate blood
Wednesday, April 9, 2008
At LUCID we believe that there's more to patient care than simply providing care to patients. For one, it means providing our patients with the highest level of dignity and respect. It also means that our patients and referring doctors should receive the most comprehensive medical imaging technology and the highest level of professional expertise in the industry. After all, what good is having the equipment without the appropriate care?
Our goal is to provide the finest in imaging services – the right procedure, at the right time, for each individual patient.
Plot No. 18, Rao & Raju Colony, Road No. 2, Banjara Hills, Hyderabad.
Tel: +91 40 23553355, 23550077, 23550088, Fax: +91 40 23609222
e mail: email@example.com
Tuesday, April 8, 2008
Painting a grim picture on the healthcare sector, the Planning Commission has blamed the shortage of medical professionals for the dismal scenario. There was a requirement of at least 600,000 more doctors, it said.
The situation is particularly bad in the public healthcare sector, a high-level group of the Commission said in a report last week.
Monday, April 7, 2008
We're aiming to build an umbrella brand: Iven Medicare, a new company, will invest in a network of hospitals that will be run by owner entrepreneurs
The funds will be used to roll out multiple networks of hospitals across urban and semi-urban centres, and will also be used to build the firm's growing interest in allied segments such as pathology laboratories and specialized health care services.
Read compelete story: http://www.livemint.com/2008/04/06234933/8216We8217re-aiming-to-b.html
April 6 : Scientists at the University of California, Los Angeles have made diagnostic tools more accurate, convenient and non-invasive, by developing Salivaomics Knowledge Base (SKB), a saliva diagnostic atlas that can work on computer or via computer simulation.
Launched during the 37th Annual Meeting of the American Association for Dental Research in Dallas, Texas, the SKB promises to serve as a catalyst for future development and expansion of salivary diagnostics.
Friday, April 4, 2008
Fortis Group companies—diagnostic chain SRL Ranbaxy and retail chain Fortis Healthworld—are considering a strategic alliance to offload minority stakes to private equity (PE) players to part fund their respective expansion plans.
SRL Ranbaxy is in advanced talks with a few PE firms as part of the pre-IPO sale. The company is looking at forging a strategic alliance with Fortis Healthworld, wherein the latter would also divest some of its stake.
Interview with Dr. Hiran,Assistant Professor, Department of Pathology, Amrita Institute of Medical Sciences and Research Centre, Cochin.
the strength of the pathologists is to keep their much deserved prominence in modern medicine resides in their unique intellectual ability to sum up and integrate an enormous amount of anatomical, histological, cytological, and molecular data -obviously obtained by various methods-and to correlate this with clinical data for establishing an accurate diagnosis and prognosis.
03-Apr-2008 - The Asia Pacific region is poised to witness heightened activity in terms of outsourced drug development to contract research organisations (CROs), with India and China remaining the preferred destinations.
Tuesday, April 1, 2008
Dr.Lal Path Labs was established in 1949 by Major S.K. Lal. One of India's largest medical diagnostics company, it is primarily Delhi-based, though it has a pan-India presence. The total employee strength stands at 900. The technical core works hand-in-hand with the commercial wing in an ongoing attempt to scale-up operations.
The company expanded rapidly to other parts of north India and across the country, such as Kolkata, Bombay and Bangalore. Starting with about 10 labs in 2005, today that number stands at 27 and plans are afoot to take this number to 50 by March 2009. Delhi itself presently has 7 satellite labs.